Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Data access

Data access restrictions

Database access

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 5 result(s)
>>> !!!!! The Cell Centered Database is no longer on serice. It has been merged with "Cell image library": https://www.re3data.org/repository/r3d100000023 !!!!! <<<<
Country
>>>!!!<<< eyemoviepedia.com was shut down in the course of 2021 https://www.zbmed.de/en/research/completed-projects/eyemoviepedia/ >>>!!!<<< The eyeMoviePedia videos moved successively to be found on PUBLISSO-Repository for Life Sciences (FRL) in the future. https://www.re3data.org/repository/r3d100013523 To view the new eyeMoviePedia collection see: https://repository.publisso.de/resource?query[0][term]=%22https%3A%2F%2Fd-nb.info%2Fgnd%2F1223212661%22
***<<<!!!>>> *** Stated 2017-08-28: To accommodate a wider scope of ophthalmic data, we launched our new Rotterdam Ophthalmic Data Repository. Please visit http://www.rodrep.com/ for all data sets. *** The ORGIDS site will no longer be updated! ***<<<!!!>>>***Through this portal, we will make data sets available that result from our glaucoma research. This includes visual fields, various imaging modalities and other data from both glaucomatous and normal subjects.The data was acquired during more than a decade.
The PRO-ACT platform houses the largest ALS clinical trials dataset ever created. It is a powerful tool for biomedical researchers, statisticians, clinicians, or anyone else interested in "Big Data." PRO-ACT merges data from existing public and private clinical trials, generating an invaluable resource for the design of future ALS clinical trials. The database will also contribute to the identification of unique observations, novel correlations, and patterns of ALS disease progression, as well as a variety of still unconsidered analyses. More than 600,000 people around them world are battling ALS. The disease strikes indiscriminately, and typically patients will die within 2-5 years following diagnosis. Currently, there are no effective treatments or a cure for ALS. Users of PRO-ACT are helping to accelerate the discovery, development, and delivery of ALS treatments, which will provide hope to patients and their families.